Abstract
AbstractThe use of regional citrate anticoagulation (RCA) in liver failure (LF) patients can lead to citrate accumulation. We aimed to evaluate serum levels of citrate and correlate them with liver function markers and with the Cat/Cai in patients under intensive care and undergoing continuous venovenous hemodiafiltration with regional citrate anticoagulation (CVVHDF-RCA). A prospective cohort study in an intensive care unit was conducted. We compared survival, clinical, laboratorial and dialysis data between patients with and without LF. Citrate was measured daily. We evaluated 200 patients, 62 (31%) with LF. Citrate was significantly higher in the LF group. Dialysis dose, filter lifespan, systemic ionized calcium and Cat/Cai were similar between groups. There were weak to moderate positive correlations between Citrate and indicators of liver function and Cat/Cai. The LF group had higher mortality (70.5% vs. 51.8%, p = 0.014). Citrate was an independent risk factor for death, OR 11.3 (95% CI 2.74–46.8). In conclusion, hypercitratemia was an independent risk factor for death in individuals undergoing CVVHDF-ARC. The increase in citrate was limited in the LF group, without clinical significance. The correlation between citrate and liver function indicators was weak to moderate.
Funder
Fundação de Amparo à Pesquisa do Estado de São Paulo
Publisher
Springer Science and Business Media LLC
Reference27 articles.
1. Fealy, N., Baldwin, I. & Bellomo, R. The effect of circuit “down-time” on uraemic control during continuous veno-venous haemofiltration. Crit. Care Resusc. 4, 266–270 (2002) (PMID: 16573439).
2. Mehta, R. L., McDonald, B. R., Aguilar, M. M. & Ward, D. M. Regional citrate anticoagulation for continuous arteriovenous hemodialysis in critically ill patients. Kidney Int. 38, 976–981. https://doi.org/10.1038/ki.1990.300 (1990).
3. Mehta, R. L., McDonald, B. R. & Ward, D. M. Regional citrate anticoagulation for continuous arteriovenous hemodialysis. An update after 12 months. Contrib. Nephrol. 93, 210–214. https://doi.org/10.1159/000420221 (1991).
4. Liu, C., Mao, Z., Kang, H., Hu, J. & Zhou, F. Regional citrate versus heparin anticoagulation for continuous renal replacement therapy in critically ill patients: A meta-analysis with trial sequential analysis of randomized controlled trials. Crit. Care 20, 144. https://doi.org/10.1186/s13054-016-1299-0 (2016).
5. Gattas, D. J. et al. A randomized controlled trial of regional citrate versus regional heparin anticoagulation for continuous renal replacement therapy in critically ill adults. Crit. Care Med. 43, 1622–1629. https://doi.org/10.1097/CCM.0000000000001004 (2015).
Cited by
1 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献